Depressive DisordersMicrodosingLSDPsilocybin

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube

Analysis of YouTube self‑reports and comments found that users predominantly describe therapeutic and enhancement benefits from psychedelic microdosing (mainly LSD and psilocybin), with notable improvements for depression and outcomes shaped by intentions and peer‑shared strategies. The study suggests microdosing may offer some benefits similar to full‑dose treatments with fewer acute adverse reactions, but repeated long‑term exposure could introduce additional risks.

Authors

  • Andersson, M.
  • Kjellgren, A.

Published

Harm Reduction Journal
individual Study

Abstract

Background

Psychedelic microdosing is the trending practice of using tiny repeated doses of psychedelic substances to facilitate a range of supposed benefits. With only a few published studies to date, the subject is still under-researched, and more knowledge is warranted. Social media and internet discussion forums have played a vital role in the growing visibility of the microdosing phenomenon, and the present study utilized YouTube contents to improve comprehension of the microdosing practice as well as the social interactions and discussions around microdosing.

Methods

Microdosing self-disclosure in YouTube videos and their following comments were qualitatively analyzed by inductive thematic analysis. Various software was utilized to enable gathering and sorting relevant data.

Results

Microdosing of psychedelic substances, primarily LSD and psilocybin, was used for therapeutic and enhancement purposes, and predominantly beneficial effects were reported. Many different applications and outcomes were discussed, and therapeutic effects for depression appeared especially noteworthy. Intentions for use were recognized as an influencing factor for the progression and outcomes of microdosing. The function of social interactions was mainly to discuss views on the microdosing phenomenon, strategies for optimal results, minimize risks, and share emotional support.

Conclusions

Potentially, microdosing could provide some of the same benefits (for certain conditions) as full-dose interventions with less risk of adverse reactions related to the sometimes intense experiences of higher doses. Microdosing may well also mean additional benefits, as well as risks, through the repeated exposure over extended periods.

Available with Blossom Pro

Research Summary of 'Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube'

Introduction

Psychedelic microdosing — the practice of taking repeated, very small doses of classic psychedelics such as LSD or psilocybin — has become highly visible in popular media and online communities but remains under‑researched. Andersson and Kjellgren note that aside from a small number of experimental studies (including one double‑blind, placebo‑controlled microdosing trial and several uncontrolled or self‑report investigations), most evidence comes from surveys and internet forums. Social media platforms, and YouTube in particular, have played a substantial role in spreading user reports, dosing strategies, and peer advice, creating a rich but methodologically challenging source of naturalistic data. This study set out to improve understanding of how psychedelic microdosing is presented and discussed on YouTube and to develop a practical method for using YouTube as a qualitative data source. The investigators aimed to characterise motives, reported effects, dosing approaches, and the social interactions that surround the practice, analysing first‑hand self‑reports in videos together with their comment threads using an inductive thematic approach.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compounds
  • Topics
  • APA Citation

    Andersson, M., & Kjellgren, A. (2019). Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube. Harm Reduction Journal, 16(1). https://doi.org/10.1186/s12954-019-0333-3

References (17)

Papers cited by this study that are also in Blossom

Psychedelics in the treatment of unipolar mood disorders: a systematic review

Rucker, J., Young, A. H., Jelen, L. A. et al. · Journal of Psychopharmacology (2016)

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

Sweat, N. W., Bates, L. W., Hendricks, P. S. · Journal of Psychoactive Drugs (2016)

Psychedelics as Medicines: An Emerging New Paradigm

Nichols, C. D., Nichols, D. E., Johnson, M. W. · Clinical Pharmacology and Therapeutics (2016)

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial

Yanakieva, S., Polychroni, N., Family, N. et al. · Psychopharmacology (2018)

A systematic study of microdosing psychedelics

Polito, V., Stevenson, R. J. · PLOS ONE (2019)

197 cited
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers

Anderson, T., Petranker, R., Rosenbaum, D. et al. · Psychopharmacology (2019)

142 cited
Powerful substances in tiny amounts An interview study of psychedelic microdosing

Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)

121 cited
Show all 17 references
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration

Fadiman, J., Korb, S. · Journal of Psychoactive Drugs (2019)

82 cited
Potential Therapeutic Effects of Psilocybin

Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)

Positive psychology in the investigation of psychedelics and entactogens: A critical review

Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

Schindler, E. A. D., Gottschalk, C. H., Weil, M. J. et al. · Journal of Psychoactive Drugs (2015)

91 cited

Cited By (14)

Papers in Blossom that reference this study

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial

Joy Donegan, C., Daldegan-Bueno, D., Sumner, R. L. et al. · Therapeutic Advances in Psychopharmacology (2025)

Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial

Murphy, R. J., Wardlaw, M., Smith, T. et al. · Journal of Humanistic Psychology (2025)

Unlocking the self: Can microdosing psychedelics make one feel more authentic?

Pop, I., Dinkelacker, J. · Nordic Studies on Alcohol and Drugs (2023)

5 cited
Microdosing psychedelics - Does it have an impact on emodiversity?

Pop, I., Dinkelacker, J. · Journal of Psychedelic Studies (2023)

Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study

Hartong, V., van Emmerik, A. · Journal of Psychoactive Drugs (2022)

Show all 14 papers

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.